Last edition
News about "KEYTRUDA "
Dr. Reddy's Injects INR 565 Crore into Russian Arm
Dr Reddy’s Laboratories Ltd has invested INR 565.4 crore in its Russian arm, Dr Reddy’s Laboratories LLC (DRL Russia), acquiring a 45.19 percent equity stake in the step-down wholly-owned subsidiary.
Keytruda | 29/07/2025 | By Dineshwori | 212
ABL Bio Signs Clinical Alliance with MSD to Evaluate ABL103 with KEYTRUDA
Under the terms of the agreement, ABL Bio will conduct a phase 1b/2 clinical trial to evaluate the safety and efficacy of ABL103 in combination with KEYTRUDA. In this combination study, MSD will supply KEYTRUDA.
KEYTRUDA | 07/10/2024 | By Aishwarya | 413
Dragonfly Therapeutics Partners with Merck to Evaluate DF9001
Dragonfly Therapeutics, Inc. has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada), to evaluate DF9001, Dragonfly's EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with advanced solid tumors expressing EGFR.
KEYTRUDA | 22/05/2024 | By Aishwarya | 415
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy